<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Scythian Biosciences Corp — News on 6ix</title>
<link>https://6ix.com/company/scythian-biosciences-corp</link>
<description>Latest news and press releases for Scythian Biosciences Corp on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Wed, 15 Apr 2026 15:34:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/scythian-biosciences-corp" rel="self" type="application/rss+xml" />
<item>
<title>Scryb Approves Proposed Name Change and Grant of Stock Options</title>
<link>https://6ix.com/company/scythian-biosciences-corp/news/scryb-approves-proposed-name-change-and-grant-of-stock-options-1</link>
<guid isPermaLink="true">https://6ix.com/company/scythian-biosciences-corp/news/scryb-approves-proposed-name-change-and-grant-of-stock-options-1</guid>
<pubDate>Wed, 15 Apr 2026 15:34:00 GMT</pubDate>
<description>Toronto, Ontario--(Newsfile Corp. - April 15, 2026) - Scryb Inc. (CSE: SCYB) ("Scryb'' or the "Company"), is pleased to announce that it intends to complete its corporate name change to NorthPalm Capital Corp., marking the next phase in the Company's evolution and reflecting a renewed strategic focus on shareholder value creation and disciplined growth.Under the new NorthPalm Capital, the Company plans to focus on timing, execution, and high-growth opportunities, supported by a more disciplined.</description>
</item>
<item>
<title>Scryb Reports 2026 AGM Results and Welcomes Veteran Capital Markets and Finance Directors</title>
<link>https://6ix.com/company/scythian-biosciences-corp/news/scryb-reports-2026-agm-results-and-welcomes-veteran-capital-markets-and-finance-directors-1</link>
<guid isPermaLink="true">https://6ix.com/company/scythian-biosciences-corp/news/scryb-reports-2026-agm-results-and-welcomes-veteran-capital-markets-and-finance-directors-1</guid>
<pubDate>Wed, 01 Apr 2026 11:06:00 GMT</pubDate>
<description>Toronto, Ontario--(Newsfile Corp. - April 1, 2026) - Scryb Inc. (CSE: SCYB) ("Scryb" or the "Company") is pleased to announce the results of its Annual General Meeting of shareholders (the "AGM") held on March 31, 2026.All resolutions presented at the AGM received overwhelming shareholder support, with more than 99% of votes cast in favour. This strong approval reflects shareholder confidence in the Company's management team, leadership, refreshed strategy, and long-term direction.Two new...</description>
</item>
<item>
<title>Scryb Reports Positive Q1 2026: Cash Increased 50%, Liabilities Down 27%, Remains Largest Shareholder of Cybeats</title>
<link>https://6ix.com/company/scythian-biosciences-corp/news/scryb-reports-positive-q1-2026-cash-increased-50percent-liabilities-down-27percent-remains-largest-shareholder-of-cybeats</link>
<guid isPermaLink="true">https://6ix.com/company/scythian-biosciences-corp/news/scryb-reports-positive-q1-2026-cash-increased-50percent-liabilities-down-27percent-remains-largest-shareholder-of-cybeats</guid>
<pubDate>Wed, 25 Feb 2026 12:01:00 GMT</pubDate>
<description>Toronto, Ontario--(Newsfile Corp. - February 25, 2026) - Scryb Inc. (CSE: SCYB) ("Scryb" or the "Company") announces that it has filed its audited consolidated financial statements and Management's Discussion and Analysis for the fiscal quarter ended December 31, 2025 ("Q1 2026"). The filings are available on SEDAR+.Q1 2026 HighlightsCash position improved by 50% to $1.2 million (from $0.8 million at September 30, 2025), with working capital rising 68% to approximately $2 million (from $1.2...</description>
</item>
<item>
<title>Scryb Reports Fiscal 2025 Results; Strengthened Balance Sheet and Significant Cybeats Exposure</title>
<link>https://6ix.com/company/scythian-biosciences-corp/news/scryb-reports-fiscal-2025-results-120300035</link>
<guid isPermaLink="true">https://6ix.com/company/scythian-biosciences-corp/news/scryb-reports-fiscal-2025-results-120300035</guid>
<pubDate>Wed, 28 Jan 2026 12:03:00 GMT</pubDate>
<description>Toronto, Ontario--(Newsfile Corp. - January 28, 2026) - Scryb Inc. (CSE: SCYB) ("Scryb'' or the "Company") announces that it has filed its audited consolidated financial statements and Management's Discussion and Analysis for the fiscal year ended September 30, 2025 ("FY2025"). The filings are available on SEDAR+.Fiscal 2025 marked a transformative year for Scryb, highlighted by a materially strengthened balance sheet, significantly reduced operating costs, and a simplified corporate structure..</description>
</item>
<item>
<title>Scryb Inc. Provides Early Warning Update on Holdings in Cybeats Technologies Corp.</title>
<link>https://6ix.com/company/scythian-biosciences-corp/news/scryb-inc-provides-early-warning-020800410</link>
<guid isPermaLink="true">https://6ix.com/company/scythian-biosciences-corp/news/scryb-inc-provides-early-warning-020800410</guid>
<pubDate>Thu, 15 Jan 2026 02:08:00 GMT</pubDate>
<description>Toronto, Ontario--(Newsfile Corp. - January 14, 2026) - Scryb Inc. (CSE: SCYB) (OTCQB: SCYRF) ("Scryb'' or the "Company"), is issuing this release to report information concerning its holdings in Cybeats Technologies Corp. (the "Issuer" or "Cybeats"). Scryb's total share ownership position of Cybeats is unchanged following all transactions outlined in this press release. Scryb outlines below that it accepted common shares in lieu of cash repayment from Cybeats Technologies Corp. due to Scryb's..</description>
</item>
<item>
<title>Cybeats and Scryb Announce Closing of Shares for Debt Transaction</title>
<link>https://6ix.com/company/scythian-biosciences-corp/news/cybeats-and-scryb-announce-closing-of-shares-for-debt-transaction</link>
<guid isPermaLink="true">https://6ix.com/company/scythian-biosciences-corp/news/cybeats-and-scryb-announce-closing-of-shares-for-debt-transaction</guid>
<pubDate>Fri, 09 Jan 2026 12:00:00 GMT</pubDate>
<description>Toronto, Ontario--(Newsfile Corp. - January 9, 2026) - Cybeats Technologies Corp. (CSE: CYBT) ("Cybeats") and Scryb Inc. (CSE: SCYB) ("Scryb") (collectively, the "Companies") are pleased to announce the closing of the debt settlement transaction previously announced on December 31, 2025 (the "Debt Settlement").Under the Debt Settlement, Cybeats has settled $1,200,000 owing under a secured debenture held by Scryb through the issuance of 10,000,000 common shares of Cybeats (the "Common Shares") at</description>
</item>
<item>
<title>Cybeats and Scryb Announce Debt Settlement Agreement</title>
<link>https://6ix.com/company/scythian-biosciences-corp/news/cybeats-and-scryb-announce-debt-settlement-agreement</link>
<guid isPermaLink="true">https://6ix.com/company/scythian-biosciences-corp/news/cybeats-and-scryb-announce-debt-settlement-agreement</guid>
<pubDate>Wed, 31 Dec 2025 12:00:00 GMT</pubDate>
<description>Toronto, Ontario--(Newsfile Corp. - December 31, 2025) - Cybeats Technologies Corp. (CSE: CYBT) ("Cybeats") and Scryb Inc. (CSE: SCYB) ("Scryb") (collectively, the "Companies") announce that they have entered into a debt settlement agreement dated December 30, 2025, to settle a secured debenture owing by Cybeats to Scryb in the amount of $1,200,000 through the issuance of 10,000,000 common shares of Cybeats (the "Common Shares") at a deemed price of $0.12 per Common Share (the "Debt...</description>
</item>
<item>
<title>Scryb Highlights New U.S. Institutional Fund Investment in Cybeats; Strengthens Long-Term Outlook</title>
<link>https://6ix.com/company/scythian-biosciences-corp/news/scryb-highlights-new-us-institutional-fund-investment-in-cybeats-strengthens-long-term-outlook</link>
<guid isPermaLink="true">https://6ix.com/company/scythian-biosciences-corp/news/scryb-highlights-new-us-institutional-fund-investment-in-cybeats-strengthens-long-term-outlook</guid>
<pubDate>Mon, 17 Nov 2025 12:00:00 GMT</pubDate>
<description>Toronto, Ontario--(Newsfile Corp. - November 17, 2025) - Scryb Inc. (CSE: SCYB) ("Scryb'' or the "Company"), is pleased to highlight the closing of an investment by U.S.-based IFCM MicroCap Fund LP, managed by Intelligent Fanatics Capital Management, into Cybeats Technologies Corp. ("Cybeats"). The investment fund was the sole participant in this $1.44 million private placement.1Scryb maintains its position as the largest institutional shareholder of Cybeats and currently holds approximately 75.</description>
</item>
<item>
<title>Scryb Grants Stock Options</title>
<link>https://6ix.com/company/scythian-biosciences-corp/news/scryb-grants-stock-options</link>
<guid isPermaLink="true">https://6ix.com/company/scythian-biosciences-corp/news/scryb-grants-stock-options</guid>
<pubDate>Wed, 01 Oct 2025 00:04:00 GMT</pubDate>
<description>Toronto, Ontario--(Newsfile Corp. - September 30, 2025) - Scryb Inc. (CSE: SCYB) (OTC Pink: SCYRF) (FSE: EIY) ("Scryb'' or the "Company") announces that it has granted 3,870,000 stock options (the "Options") to various employees, directors, officers and consultants of the Company.Each Option is exercisable at a price of $0.12 for one common share of the Company (each a "Common Share") for a period of five years from the date of grant and are being issued under the terms of the Company's Omnibus.</description>
</item>
<item>
<title>Scryb Closes Oversubscribed Private Placement for over $1.4M</title>
<link>https://6ix.com/company/scythian-biosciences-corp/news/scryb-closes-oversubscribed-private-placement-for-over-dollar14m</link>
<guid isPermaLink="true">https://6ix.com/company/scythian-biosciences-corp/news/scryb-closes-oversubscribed-private-placement-for-over-dollar14m</guid>
<pubDate>Fri, 26 Sep 2025 23:03:00 GMT</pubDate>
<description>Toronto, Ontario--(Newsfile Corp. - September 26, 2025) - Scryb Inc. (CSE: SCYB) ("Scryb" or the "Company"), is pleased to announce it has completed its previously announced upsized non-brokered private placement offering, issuing 14,709,700 units of the Company (each, a "Unit"), at a price of $0.10 per Unit, for gross proceeds of $1,470,970 (the "Offering"). The original offering was announced for up to 6,000,000 Units of the Company on September 17, 2025, and was upsized for up to 15,000,000..</description>
</item>
<item>
<title>Scryb Announces Upsize of Private Placement Following Strong Investor Demand</title>
<link>https://6ix.com/company/scythian-biosciences-corp/news/scryb-announces-upsize-of-private-placement-following-strong-investor-demand</link>
<guid isPermaLink="true">https://6ix.com/company/scythian-biosciences-corp/news/scryb-announces-upsize-of-private-placement-following-strong-investor-demand</guid>
<pubDate>Fri, 19 Sep 2025 22:59:00 GMT</pubDate>
<description>Toronto, Ontario--(Newsfile Corp. - September 19, 2025) - Scryb Inc. (CSE: SCYB) ("Scryb" or the "Company") is pleased to announce that due to strong market demand, it intends to upsize its previously announced non-brokered private placement (the "Offering") to $1,500,000, or 15,000,000 units of the Company (each, a "Unit") at a price of $0.10 per Unit.Each Unit will consist of one common share (a "Common Share") and one half of one common share purchase warrant (each a full warrant a...</description>
</item>
<item>
<title>Scryb Announces Non-Brokered Private Placement</title>
<link>https://6ix.com/company/scythian-biosciences-corp/news/scryb-announces-non-brokered-private-placement</link>
<guid isPermaLink="true">https://6ix.com/company/scythian-biosciences-corp/news/scryb-announces-non-brokered-private-placement</guid>
<pubDate>Wed, 17 Sep 2025 20:05:00 GMT</pubDate>
<description>Toronto, Ontario--(Newsfile Corp. - September 17, 2025) - Scryb Inc. (CSE: SCYB) ("Scryb'' or the "Company"), is pleased to announce its intention to complete a non-brokered private placement (the "Offering") of up to 6,000,000 units of the Company (each, a "Unit") at a price of $0.10 per Unit, for gross proceeds of up to $600,000Each Unit will consist of one common share (a "Common Share") and one half of one common share purchase warrant (each a full warrant a "Warrant"). Each Warrant entitles</description>
</item>
<item>
<title>Scryb Reports Financial Results for Q3 2025: Positive Outlook for Cybeats Technologies Corp.</title>
<link>https://6ix.com/company/scythian-biosciences-corp/news/scryb-reports-financial-results-for-q3-2025-positive-outlook-for-cybeats-technologies-corp</link>
<guid isPermaLink="true">https://6ix.com/company/scythian-biosciences-corp/news/scryb-reports-financial-results-for-q3-2025-positive-outlook-for-cybeats-technologies-corp</guid>
<pubDate>Wed, 03 Sep 2025 11:20:00 GMT</pubDate>
<description>Toronto, Ontario--(Newsfile Corp. - September 3, 2025) - Scryb Inc. (CSE: SCYB) ("Scryb'' or the "Company") has filed financial results for its third quarter ended June 30, 2025 ("Q3 2025"), and also provides commentary on Scryb's largest holding, Cybeats, which filed its second quarter ended June 30, 2025 Interim Financial Statements and Management's Discussion and Analysis ("MD&A"). Scryb's reported results for Q3 2025 reflect the transition to equity accounting for Cybeats following the...</description>
</item>
<item>
<title>Scryb Announces Effective Date of Proposed Share Consolidation</title>
<link>https://6ix.com/company/scythian-biosciences-corp/news/scryb-announces-effective-date-of-proposed-share-consolidation</link>
<guid isPermaLink="true">https://6ix.com/company/scythian-biosciences-corp/news/scryb-announces-effective-date-of-proposed-share-consolidation</guid>
<pubDate>Fri, 08 Aug 2025 02:20:00 GMT</pubDate>
<description>Toronto, Ontario--(Newsfile Corp. - August 7, 2025) - Scryb Inc. (CSE: SCYB) (OTC Pink: SCYRF) ("Scryb'' or the "Company"), is pleased to announce that further to its news release dated July 25, 2025, the Company will proceed with the consolidation of its issued and outstanding common shares (the "Common Shares") on the basis of one (1) new Common Share for every ten (10) old Common Shares (the "Consolidation"), effective as of August 13, 2025. The Consolidation ...</description>
</item>
<item>
<title>Scryb Announces Proposed Share Consolidation</title>
<link>https://6ix.com/company/scythian-biosciences-corp/news/scryb-announces-proposed-share-consolidation</link>
<guid isPermaLink="true">https://6ix.com/company/scythian-biosciences-corp/news/scryb-announces-proposed-share-consolidation</guid>
<pubDate>Fri, 25 Jul 2025 11:03:00 GMT</pubDate>
<description>Toronto, Ontario--(Newsfile Corp. - July 25, 2025) - Scryb Inc. (CSE: SCYB) ("Scryb" or the "Company") announces a proposed consolidation of the common shares of the Company (the "Common Shares") on the basis of ten (10) pre-consolidation Common Shares for every one (1) post-consolidation Common Share (the "Consolidation"). The Company currently has 323,187,472 Common Shares issued and outstanding, and following the Consolidation, will have approximately 32,318,747 Common Shares issued and outst</description>
</item>
<item>
<title>Scryb Appoints Daniel M. Proska as President</title>
<link>https://6ix.com/company/scythian-biosciences-corp/news/scryb-appoints-daniel-m-proska-as-president</link>
<guid isPermaLink="true">https://6ix.com/company/scythian-biosciences-corp/news/scryb-appoints-daniel-m-proska-as-president</guid>
<pubDate>Mon, 21 Jul 2025 11:28:00 GMT</pubDate>
<description>Toronto, Ontario--(Newsfile Corp. - July 21, 2025) - Scryb Inc. (CSE: SCYB) ("Scryb" or the "Company") is pleased to announce the appointment of Daniel M. Proska to the role of President, effective immediately. In this new capacity, Mr. Proska will help guide Scryb's strategy, oversee Company investments, and further strengthen relationships with its operating companies and other key stakeholders. Earlier in his career, he was part of the leadership team at a technology company that scaled reven</description>
</item>
<item>
<title>IIROC Trading Halt - SCYB</title>
<link>https://6ix.com/company/scythian-biosciences-corp/news/iiroc-trading-halt-scyb</link>
<guid isPermaLink="true">https://6ix.com/company/scythian-biosciences-corp/news/iiroc-trading-halt-scyb</guid>
<pubDate>Thu, 26 Jul 2018 11:43:00 GMT</pubDate>
<description>IIROC Trading Halt - SCYB Canada NewsWire VANCOUVER, July 26, 2018 VANCOUV...</description>
</item>
<item>
<title>IIROC Trading Resumption - SCYB</title>
<link>https://6ix.com/company/scythian-biosciences-corp/news/iiroc-trading-resumption-scyb</link>
<guid isPermaLink="true">https://6ix.com/company/scythian-biosciences-corp/news/iiroc-trading-resumption-scyb</guid>
<pubDate>Mon, 09 Apr 2018 18:15:00 GMT</pubDate>
<description>IIROC Trading Resumption - SCYB Canada NewsWire VANCOUVER, April 9, 2018 V...</description>
</item>
<item>
<title>Scythian Biosciences Corp. Begins Trading on the TSXV under Symbol "SCYB"</title>
<link>https://6ix.com/company/scythian-biosciences-corp/news/scythian-biosciences-corp-begins-trading-on-the-tsxv-under-symbol-scyb</link>
<guid isPermaLink="true">https://6ix.com/company/scythian-biosciences-corp/news/scythian-biosciences-corp-begins-trading-on-the-tsxv-under-symbol-scyb</guid>
<pubDate>Tue, 08 Aug 2017 14:42:00 GMT</pubDate>
<description>Scythian Biosciences Corp. Begins Trading on the TSXV under Symbol "SCYB" Canada N...</description>
</item>
<item>
<title>IIROC Trading Halt - KIT</title>
<link>https://6ix.com/company/scythian-biosciences-corp/news/iiroc-trading-halt-kit</link>
<guid isPermaLink="true">https://6ix.com/company/scythian-biosciences-corp/news/iiroc-trading-halt-kit</guid>
<pubDate>Thu, 16 Feb 2017 22:30:00 GMT</pubDate>
<description>IIROC Trading Halt - KIT Canada NewsWire VANCOUVER, Feb. 16, 2017 VANCOUVE...</description>
</item>
</channel>
</rss>